Gsa Capital Partners LLP Cerus Corp Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Cerus Corp stock. As of the latest transaction made, Gsa Capital Partners LLP holds 959,978 shares of CERS stock, worth $1.72 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
959,978
Previous 1,465,022 34.47%
Holding current value
$1.72 Million
Previous $2.58 Million 35.22%
% of portfolio
0.13%
Previous 0.18%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$1.7 - $2.39 $858,574 - $1.21 Million
-505,044 Reduced 34.47%
959,978 $1.67 Million
Q2 2024

Aug 15, 2024
BUY
$1.62 - $2.04 $985,787 - $1.24 Million
608,511 Added 71.05%
1,465,022 $2.58 Million
Q1 2024

May 03, 2024
SELL
$1.66 - $2.42 $244,582 - $356,560
-147,339 Reduced 14.68%
856,511 $1.62 Million
Q4 2023

Feb 16, 2024
SELL
$1.25 - $2.35 $360,253 - $677,277
-288,203 Reduced 22.31%
1,003,850 $2.17 Million
Q3 2023

Nov 15, 2023
BUY
$1.5 - $3.07 $1.84 Million - $3.77 Million
1,226,757 Added 1878.76%
1,292,053 $2.09 Million
Q2 2023

Aug 14, 2023
BUY
$1.79 - $2.9 $116,879 - $189,358
65,296 New
65,296 $160,000
Q4 2022

Feb 13, 2023
BUY
$3.38 - $4.22 $575,671 - $718,737
170,317 New
170,317 $622,000
Q2 2022

Aug 09, 2022
BUY
$4.41 - $5.69 $38,737 - $49,980
8,784 Added 37.11%
32,456 $172,000
Q1 2022

May 11, 2022
SELL
$4.81 - $6.99 $664,539 - $965,724
-138,158 Reduced 85.37%
23,672 $130,000
Q4 2021

Feb 14, 2022
BUY
$5.97 - $7.93 $432,544 - $574,552
72,453 Added 81.06%
161,830 $1.1 Million
Q3 2021

Nov 12, 2021
BUY
$4.79 - $6.68 $139,336 - $194,314
29,089 Added 48.25%
89,377 $544,000
Q2 2021

Aug 05, 2021
SELL
$5.35 - $6.35 $976,155 - $1.16 Million
-182,459 Reduced 75.16%
60,288 $356,000
Q1 2021

May 10, 2021
BUY
$5.68 - $7.87 $1.28 Million - $1.77 Million
225,146 Added 1279.17%
242,747 $1.46 Million
Q4 2020

Feb 03, 2021
SELL
$5.25 - $8.56 $299,097 - $487,671
-56,971 Reduced 76.4%
17,601 $122,000
Q3 2020

Nov 06, 2020
BUY
$5.78 - $7.47 $431,026 - $557,052
74,572 New
74,572 $467,000
Q3 2019

Nov 12, 2019
SELL
$4.86 - $6.05 $113,767 - $141,624
-23,409 Closed
0 $0
Q2 2019

Aug 06, 2019
BUY
$4.51 - $6.6 $47,652 - $69,735
10,566 Added 82.27%
23,409 $132,000
Q1 2019

May 15, 2019
SELL
$5.16 - $6.85 $91,971 - $122,094
-17,824 Reduced 58.12%
12,843 $80,000
Q4 2018

Feb 12, 2019
SELL
$4.89 - $7.16 $62,885 - $92,077
-12,860 Reduced 29.54%
30,667 $155,000
Q3 2018

Nov 13, 2018
SELL
$6.89 - $7.78 $960,466 - $1.08 Million
-139,400 Reduced 76.21%
43,527 $314,000
Q2 2018

Aug 09, 2018
BUY
$5.19 - $7.25 $949,391 - $1.33 Million
182,927 New
182,927 $1.22 Million

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email